Sampson HA, et al. - Researchers aimed at identifying the optimal dose, adverse events (AEs), and efficacy of a peanut patch for peanut allergy treatment. A prominent treatment response was yielded via the 250-μg peanut patch when compared to the placebo patch, following 12 months of therapy. However, a necessity arose for a phase 3 trial.